Cargando…
Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone
BACKGROUND: Malignant ascites (MA) is associated with poor prognosis and limited palliative therapeutic options. Therefore, quality of life (QoL) assessment is of particular importance to demonstrate new treatment value. Following the demonstration of the superiority of catumaxomab and paracentesis...
Autores principales: | Wimberger, P., Gilet, H., Gonschior, A-K., Heiss, M. M., Moehler, M., Oskay-Oezcelik, G., Al-Batran, S-E., Schmalfeldt, B., Schmittel, A., Schulze, E., Parsons, S. L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403730/ https://www.ncbi.nlm.nih.gov/pubmed/22734013 http://dx.doi.org/10.1093/annonc/mds178 |
Ejemplares similares
-
Case of Ascites Cured by Paracentesis and Compression
por: Vieira, A. X. Lopes, et al.
Publicado: (1878) -
EUS-guided paracentesis and ascitic fluid analysis
por: Chin, Matthew A.
Publicado: (2018) -
Ultrasound Findings in Suspected Ascites Referred for Paracentesis
por: Droste, Jan Christian, et al.
Publicado: (2021) -
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
por: Heiss, Markus M, et al.
Publicado: (2010) -
Paracentesis Tympani
por: Hunter, Kennedy
Publicado: (1941)